Company overview

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), a serious form of fatty liver disease. Left untreated, MASH can lead to progressive liver scarring, cirrhosis, liver failure, liver cancer, need for transplant and premature mortality. Our goal is to halt or reverse liver scarring (fibrosis) and resolve MASH before patients experience the devastating complications of cirrhosis. Learn more about us at www.madrigalpharma.com
Founded in 2016
Conshohocken, Pennsylvania, USA
871 employees (48 in marketing)
100% recommend to a friend
100% positive business outlook

Salaries

Typical salary range

$263,000 – $321,000

/ yr

Help build salary transparency at Madrigal Pharmaceuticals

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

8 open now

Headcount trend

Company growth over the last 12 months

Headcount +56.1% year over year

Funding

Total funding

$1.6B

Last raise

Post IPO Debt, 5 months ago

Audience

Monthly website visitors
32.4K
Month over month+19.2%
Quarter over quarter+19.2%
Top sourceSearch (50.2%)
Ad budget per month$0.0
Average search rank53
Traffic source mix
Search
50.2%
Direct
38.5%
Referral
6.1%
Social
3.7%
Paid referral
1.3%

LinkedIn followers

Follower count and growth

Total followers

73.8K

12-mo growth

+56.5%

Monthly growth

+4.2%

News

Links